Quick Answer
BIOLIFE SOLUTIONS INC reported Cash and Equivalents of $33.04 million for fiscal year 2025.
BIOLIFE SOLUTIONS INC Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2025 | $33.04M | -63.9% |
| 2024 | $91.54M | +228.1% |
| 2023 | $27.90M | +43.5% |
| 2022 | $19.44M | -72.2% |
| 2021 | $69.86M | -22.7% |
| 2020 | $90.40M | +1302.0% |
| 2019 | $6.45M | -69.6% |
| 2019 | $21.20M | +8.1% |
| 2019 | $19.62M | -38.4% |
| 2019 | $31.82M | +3.8% |
| 2018 | $30.66M | -5.3% |
| 2018 | $32.38M | +128.6% |
| 2018 | $14.17M | +101.4% |
| 2018 | $7.03M | +5.6% |
| 2017 | $6.66M | +373.9% |
| 2016 | $1.41M | -35.3% |
| 2015 | $2.17M | -14.4% |
| 2014 | $2.54M | +1524.6% |
| 2013 | $156.3K | -20.5% |
| 2012 | $196.5K | +1065.1% |
| 2011 | $16.9K | +425.2% |
| 2010 | $3.2K | -97.7% |
| 2009 | $139.2K | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $29.48M | +23.0% | -7.6% |
| June 30, 2025 | $31.90M | +44.9% | -52.3% |
| March 31, 2025 | $66.94M | +125.4% | -29.8% |
| December 31, 2024 | $95.39M | +186.3% | +297.8% |
| September 30, 2024 | $23.98M | +24.7% | +8.9% |
| June 30, 2024 | $22.01M | +2.9% | -25.9% |
| March 31, 2024 | $29.69M | +55.4% | -10.9% |
| December 31, 2023 | $33.32M | +71.4% | +73.2% |
- BIOLIFE SOLUTIONS INC showed a decrease of -63.9% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2009–2025 period, BIOLIFE SOLUTIONS INC’s cash and equivalents has grown by 23642.6% (from $139.2 thousand to $33.04 million).
- The most recent figure is from BIOLIFE SOLUTIONS INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: